Infusion Therapy for Ulcerative Colitis in North Baltimore, MD

We understand the complexities of ulcerative colitis, a chronic disease affecting the colon and rectum. Infusion therapy is one of the treatment methods offered at the clinic for patients with moderate to severe ulcerative colitis who have not responded well to oral medications or other treatment forms.

Patients at Jean Walter Infusion Center receive infusion therapy with medications that include Infliximab (Remicade), Vedolizumab (Entyvio), and Ustekinumab (Stelara). These biologics target and suppress the parts of the immune system causing inflammation in the colon and rectum. Each medication is delivered directly into the bloodstream, allowing it to reach the inflamed areas quickly and efficiently.

The team carefully monitors patients during the infusion, which is delivered slowly through an IV line over a few hours. The frequency of infusions depends on each patient’s unique treatment plan, but they are typically scheduled every few weeks or months.

The main benefits of receiving infusion therapy include effective treatment of moderate to severe ulcerative colitis, long-lasting effects, increased patient adherence, and improved quality of life. The team works closely with patients to ensure they understand the potential benefits and risks associated with infusion therapy, ensuring they receive the most suitable treatment for their individual medical needs and lifestyle.

Potential risks and side effects, such as reactions at the infusion site or allergic reactions, are thoroughly discussed before the start of therapy. Our team prioritizes patient safety and comfort, making it their goal to ensure that each infusion session is a positive experience.

At Jean Walter Infusion Center, under the guidance of Dr. Nasser Nasseri, patients can expect a personalized approach to their ulcerative colitis treatment, with a focus on improving their quality of life.

We provide specialized care to patients suffering from ulcerative colitis. He recognizes the chronic nature of this condition, characterized by inflammation as well as ulcers in the lining of the colon and rectum. The disease can cause severe discomfort, frequent diarrhea, abdominal pain, and other distressing symptoms, leading to potential permanent tissue damage.

We utilize infusion therapy as a central aspect of managing this condition. This method works by delivering medication directly into the bloodstream through an intravenous (IV) line, allowing the medication to take effect more rapidly and efficiently than oral medication.

The medications typically used in infusion therapy for ulcerative colitis are biologics and immunomodulators. Biologics are medications derived from living organisms, like proteins, targeting specific proteins in the patient’s body that are responsible for contributing to inflammation. Immunomodulators suppress the immune system and target T cells and other immune cells involved in the inflammatory response.

We often prescribe biologic medications like infliximab, adalimumab, and vedolizumab, monoclonal antibodies that neutralize specific proteins involved in inflammation. For example, infliximab blocks a protein called tumor necrosis factor-alpha (TNF-alpha), a significant contributor to inflammation in the body. Vedolizumab works by blocking a specific protein found in certain immune system cells, preventing these cells from causing inflammation in areas like the gut.

Infusion therapy offers rapid and effective delivery of potent medications, leading to faster symptom control. By bypassing the digestive tract, it also minimizes gastrointestinal side effects. The direct delivery of powerful anti-inflammatory medications provides significant relief, improves the quality of life, and promotes long-term remission in ulcerative colitis patients, improving their ability to manage the condition effectively.

The frequency of treatments depends on the specific medication, the severity of the patient’s symptoms, the nature of their condition, as well as their response to the medication. We emphasize regular monitoring to assess the effectiveness of treatment, check for any adverse effects, and adjust the regimen accordingly.

We specialize in administering infusion therapy for a variety of conditions, including moderate to severe forms of ulcerative colitis. Our team is experienced in evaluating patients’ medical histories and current conditions to determine the suitability of this form of treatment.

Infusion therapy is a recommended treatment for those with ulcerative colitis who have not found relief from other treatments, including first-line medications such as aminosalicylates or corticosteroids, or those who have experienced significant side effects from these treatments. Our team is also able to assist patients with persistent symptoms despite optimal medical therapy, including frequent bloody diarrhea, abdominal pain and cramping, urgency and incontinence, weight loss, or malnutrition.

Our dedicated team aims to reduce the frequency and severity of flare-ups through this treatment. Infusion therapy can be a highly effective and even life-changing option for those facing frequent flare-ups and those with a high risk of complications from ulcerative colitis, such as toxic megacolon or colorectal cancer, or those with extensive or pancolitis.

However, it’s of utmost importance to note that while infusion therapy can be a game-changer for many, it is not suitable for everyone with ulcerative colitis. There can be side effects, but they are usually transient and well tolerated, and they may not be suitable for patients who have certain health concerns or conditions. Hence, a thorough medical evaluation is conducted by Dr. Nasser Nasseri and his team before starting this type of treatment. The decision to initiate infusion therapy is made on a case-by-case basis, ensuring the best possible outcome for each patient. For more information, contact us or book an appointment online. We are conveniently located at 3333 N. Calvert St, Suite 540A, Baltimore, MD 21218. We serve clients from North Baltimore MD, Dundalk MD, Halethrope MD, Ferndale MD, Yorktown MD, and surrounding areas.